UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines

PloS one, 2013-03, Vol.8 (3), p.e59180-e59180

2013

Volltextzugriff (PDF)

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer

Cell death & disease, 2022-10, Vol.13 (10), p.909-13, Article 909

2022

Volltextzugriff (PDF)

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines

International journal of oncology, 2022-07, Vol.61 (1), p.1, Article 89

2022

Volltextzugriff (PDF)

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

Modern pathology, 2012-06, Vol.25 (6), p.885-892

2012

Volltextzugriff (PDF)

MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells

Gynecologic oncology, 2017-04, Vol.145 (1), p.159-166

2017

Volltextzugriff (PDF)

Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells

Fertility and sterility, 2013-09, Vol.100 (3), p.770-776

2013

Volltextzugriff (PDF)

ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer

PloS one, 2018-03, Vol.13 (3), p.e0195213-e0195213

2018

Volltextzugriff (PDF)

Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells

Fertility and sterility, 2010-12, Vol.94 (7), p.2838-2842

2010

Volltextzugriff (PDF)

Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients

PloS one, 2016-10, Vol.11 (10), p.e0164230-e0164230

2016

Volltextzugriff (PDF)

PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array

Journal of immunological methods, 2014-10, Vol.412, p.42-52

2014

Volltextzugriff (PDF)

Outcome in serous ovarian cancer is not associated with LATS expression

Journal of cancer research and clinical oncology, 2019-11, Vol.145 (11), p.2737-2749

2019

Volltextzugriff (PDF)

Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models

STAR protocols, 2024-09, Vol.5 (3), p.103274, Article 103274

2024

Volltextzugriff (PDF)

Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients

Oncotarget, 2016-08, Vol.7 (32), p.51674-51686

2016

Volltextzugriff (PDF)

MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies

Microsystems & nanoengineering, 2022-12, Vol.8 (1), p.130-130, Article 130

2022

Volltextzugriff (PDF)

Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids

Glycobiology (Oxford), 2015-04, Vol.25 (4), p.351-356

2015

Volltextzugriff (PDF)

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study

Reproductive biology and endocrinology, 2012-04, Vol.10 (1), p.30-30, Article 30

2012

Volltextzugriff (PDF)

Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin

Fertility and sterility, 2011-04, Vol.95 (5), p.1579-1583

2011

Volltextzugriff (PDF)

A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker

International journal of molecular medicine, 2014-04, Vol.33 (4), p.784-794

2014

Volltextzugriff (PDF)

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells

BMC molecular biology, 2014-10, Vol.15 (1), p.24-24

2014

Volltextzugriff (PDF)

Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells

Gynecologic oncology, 2015-08, Vol.138 (2), p.363-371

2015

Volltextzugriff (PDF)

MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3′-deoxyadenosine) in vitro

Oncology letters, 2012-02, Vol.3 (2), p.441-444

2012

Volltextzugriff (PDF)

Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities

Anti-cancer drugs, 2009-06, Vol.20 (5), p.321-333

2009

Volltextzugriff (PDF)

Cordycepin (3'-deoxyadenosine), an inhibitor of mRNA polyadenylation, suppresses proliferation and activates apoptosis in human epithelial endometriotic cells in vitro

Gynecologic and obstetric investigation, 2011-08, Vol.72 (1), p.43-49

2011

Volltextzugriff (PDF)

Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study

BMC cancer, 2011-10, Vol.11 (1), p.463-463, Article 463

2011

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(48)
Bücher
(1)

Sprache

Englisch
(48)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells

Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells

ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer

Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells

Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients

PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array

Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis

Outcome in serous ovarian cancer is not associated with LATS expression

Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models

Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients

MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies

Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study

Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin

A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells

Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells

MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3′-deoxyadenosine) in vitro

Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities

Cordycepin (3'-deoxyadenosine), an inhibitor of mRNA polyadenylation, suppresses proliferation and activates apoptosis in human epithelial endometriotic cells in vitro

Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study

Suchergebnisse filtern